Replies to post #145687 on Biotech Values

[iandy]

The second leg of the ARIA story is AP26113. We'll only get results from the Phase I in September, but there are already some good patient anecdotes out there.

Are the 113 patient anecdotes you refer to in ALK, EGFR, or both?

[zipjet]

AML - Hundreds of random mutations in leukemia related to aging, not cancer


http://news.wustl.edu/news/Pages/24042.aspx

[vinmantoo]

Peter,

Thanks for the detailed synopsis. Aria is certainly worth a look.